Valuation Shenyang Xingqi Pharmaceutical Co.,Ltd.

Equities

End-of-day quote Shenzhen S.E. Other stock markets 2025-12-10			5-day change	1st Jan Change
71.53 ^CNY	-2.35%		+0.15%	+43.51%

Dec. 08	Xingqi Pharmaceutical's 39 Products Stay in China's Insurance Drug Catalogue	MT
Oct. 28	Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2019	2020	2021	2022	2023	2024
Capitalization ¹	5,869	7,612	11,263	11,076	22,715	12,229
Change	-	29.71%	47.96%	-1.66%	105.08%	-46.16%
Enterprise Value (EV) ¹	5,909	7,655	10,688	10,575	22,314	12,074
Change	-	29.55%	39.62%	-1.06%	111.01%	-45.89%
P/E ratio	163x	88.2x	57.5x	51.9x	94.5x	36.2x
PBR	9.6x	11.5x	8.96x	7.14x	13.4x	7.68x
PEG	-	1x	0x	37.92x	7.8x	0.9x
Capitalization / Revenue	10.8x	11.1x	11x	8.86x	15.5x	6.29x
EV / Revenue	10.9x	11.1x	10.4x	8.46x	15.2x	6.21x
EV / EBITDA	76x	50.9x	36x	35.8x	66.1x	24.2x
EV / EBIT	158x	72.6x	44.5x	45.7x	85.8x	29.6x
EV / FCF	603x	-459x	84x	-79.4x	-1,071x	58.1x
FCF Yield	0.17%	-0.22%	1.19%	-1.26%	-0.09%	1.72%
Dividend per Share ²	0.0456	0.0911	0.2369	0.5466	1.888	1.071
Rate of return	0.17%	0.26%	0.48%	1.2%	2.03%	2.15%
EPS ²	0.164	0.3936	0.8664	0.8783	0.9847	1.379
Distribution rate	27.8%	23.1%	27.3%	62.2%	192%	77.7%
Net sales ¹	542.4	688.7	1,028	1,250	1,468	1,943
EBITDA ¹	77.72	150.2	296.8	295.5	337.8	499.8
EBIT ¹	37.49	105.4	240.3	231.2	259.9	408.4
Net income ¹	35.89	87.98	194.7	211.7	240	338.1
Net Debt ¹	40.04	42.78	-575.1	-501.6	-401.3	-154.8
Reference price ²	26.73	34.70	49.85	45.58	93.02	49.84
Nbr of stocks (in thousands)	219,520	219,343	225,921	242,995	244,195	245,349
Announcement Date	4/19/20	4/19/21	4/19/22	4/19/23	4/18/24	4/21/25

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	-	-	-	-	2.56B
MERCK KGAA	17.94x	2.81x	9.84x	1.95%	59.74B
KYOWA KIRIN CO., LTD.	23.61x	2.3x	10.28x	2.39%	8.37B
HALOZYME THERAPEUTICS, INC.	11.42x	5.96x	9.03x	-	7.28B
SK BIOPHARMACEUTICALS CO., LTD.	59.45x	14.45x	44.24x	-.--%	7.2B
YUHAN CORPORATION	71.87x	3.84x	43.82x	0.43%	5.92B
INDIVIOR PLC	20.46x	3.7x	10.7x	-.--%	4.5B
BETTA PHARMACEUTICALS CO., LTD.	35.55x	6.03x	19.89x	0.75%	2.87B
SUPERNUS PHARMACEUTICALS, INC.	-58.73x	-	-	-	2.6B
Average	22.70x	5.58x	21.11x	0.92%	11.23B
Weighted average by Cap.	22.82x	4.08x	14.84x	1.59%